Inventor
BAR LILIANA
IL28 patents
⚠️ This page may combine multiple inventors who share the name “BAR LILIANA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
OMRIX BIOPHARMACEUTICALS LTD
9 patentsUS8354249B2Jan 15, 2013
Intravenous immunoglobulin composition
OMRIX BIOPHARMACEUTICALS LTD13 citations83
US11993797B2May 28, 2024
Thrombin solution and methods of use thereof
OMRIX BIOPHARMACEUTICALS LTD0 citations61
US11225652B2Jan 18, 2022
Thrombin solution and methods of use thereof
OMRIX BIOPHARMACEUTICALS LTD0 citations61
US10479987B2Nov 19, 2019
Thrombin solution and methods of use thereof
OMRIX BIOPHARMACEUTICALS LTD0 citations51
US9896716B2Feb 20, 2018
Protein assay
OMRIX BIOPHARMACEUTICALS LTD0 citations51
US9212357B2Dec 15, 2015
Thrombin solution and methods of use thereof
OMRIX BIOPHARMACEUTICALS LTD0 citations51
US9427490B2Aug 30, 2016
Gelatin sponge comprising an active ingredient, its preparation and use
OMRIX BIOPHARMACEUTICALS LTD0 citations50
US9796770B2Oct 24, 2017
Immunoglobulin reduced in thrombogenic agents and preparation thereof
OMRIX BIOPHARMACEUTICALS LTD0 citations49
US9326998B2May 3, 2016
Compositions suitable for treatment of spinal disease, disorder or condition
OMRIX BIOPHARMACEUTICALS LTD0 citations48
NUR ISRAEL
5 patentsUS8475812B2Jul 2, 2013
Gelatin sponge comprising an active ingredient, its preparation and use
NUR ISRAEL6 citations82
US9365635B2Jun 14, 2016
Intravenous immunoglobulin composition
NUR ISRAEL3 citations71
US8322637B2Dec 4, 2012
Method of micronization
NUR ISRAEL4 citations62
US8563288B2Oct 22, 2013
Removal of plasmin or plasminogen from cryoprecipitate
NUR ISRAEL2 citations61
US8981058B2Mar 17, 2015
Gelatin sponge comprising an active ingredient, its preparation and use
NUR ISRAEL1 citations60
OMRIX BIOPHARMACEUTICALS INC
3 patentsUS7125569B2Oct 24, 2006
Removal of plasmin(ogen) from protein solutions
OMRIX BIOPHARMACEUTICALS INC83 citations96
US6468733B2Oct 22, 2002
Method of the inactivation of viruses by a solvent-detergent combination and nanofiltration
OMRIX BIOPHARMACEUTICALS INC42 citations92
US7641918B2Jan 5, 2010
Plasma cryoprecipitate substantially free of plasminogen
OMRIX BIOPHARMACEUTICALS INC6 citations72